Natural Investments LLC grew its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 9.4% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,514 shares of the healthcare conglomerate’s stock after purchasing an additional 215 shares during the quarter. Natural Investments LLC’s holdings in UnitedHealth Group were worth $784,000 at the end of the most recent reporting period.
Other hedge funds have also added to or reduced their stakes in the company. Citizens National Bank Trust Department raised its stake in UnitedHealth Group by 1.0% during the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock worth $9,368,000 after buying an additional 170 shares during the period. Caitlin John LLC raised its stake in UnitedHealth Group by 14.8% during the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock worth $451,000 after buying an additional 111 shares during the period. Triumph Capital Management acquired a new stake in UnitedHealth Group during the 2nd quarter worth $1,324,000. Wealth Effects LLC increased its holdings in UnitedHealth Group by 14.4% during the 2nd quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock worth $1,463,000 after purchasing an additional 591 shares in the last quarter. Finally, Arlington Partners LLC bought a new position in UnitedHealth Group during the 2nd quarter worth about $2,229,000. Institutional investors and hedge funds own 87.86% of the company’s stock.
Wall Street Analyst Weigh In
A number of research firms have issued reports on UNH. Wells Fargo & Company increased their target price on UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a report on Tuesday, October 7th. Zacks Research upgraded UnitedHealth Group from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. Bank of America increased their target price on UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a report on Wednesday. UBS Group restated a “buy” rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Finally, Robert W. Baird restated an “underperform” rating and issued a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have given a Sell rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Hold” and a consensus price target of $383.09.
UnitedHealth Group Trading Down 3.6%
UnitedHealth Group stock opened at $354.30 on Friday. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market capitalization of $320.88 billion, a P/E ratio of 15.35, a PEG ratio of 2.29 and a beta of 0.47. The stock has a 50-day simple moving average of $318.21 and a 200 day simple moving average of $349.25.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter in the previous year, the business posted $6.80 EPS. The company’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were issued a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- What is the Dogs of the Dow Strategy? Overview and Examples
- Bassett Furniture: Buy Now, Sit Back, and Collect Dividends
- Best Stocks Under $10.00
- AST SpaceMobile’s Big Win: Shares Soar on New Deal With Verizon
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Catch the Next Bitcoin Rally With These 3 ETFs
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.